Stability during lung clot removal procedure
Part of Heart & circulation, Lungs & breathing clinical trials.
This study looks at patients having a procedure to remove blood clots from the lungs. It checks how stable their heart and breathing are during the procedure to help doctors know what to expect.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a serious blood clot in your lungs (high or intermediate-high risk).
- You are scheduled to have a procedure to remove the clot through a vein (percutaneous pulmonary thrombectomy).
- You must not have a low-risk clot or be in shock when arriving for the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device that removes blood clots from the lungs through a small tube. It is for people with a recent pulmonary embolism who have slightly strained hearts but stable blood pressure.
This trial tests the Vibrato Aspiration System, a device that suctions blood clots from the lungs in people with a recent pulmonary embolism (PE). It aims to see if the procedure is safe and works well for removing clots.
This study compares two ways to treat a large blood clot in the lungs that is causing life-threatening symptoms. One method uses a device to remove the clot, the other uses medicine to dissolve it.
This trial tests a new device (the Akura Thrombectomy System) that removes blood clots from the lungs in people with a sudden, severe pulmonary embolism. It aims to see if the device is safe and effective at improving blood flow and heart function.
This study tests a procedure to remove blood clots from the lungs in people with moderate or severe pulmonary embolism. It may help reduce strain on the heart and improve recovery.
This trial tests a procedure to remove blood clots from the lungs in people with a serious pulmonary embolism. It may help improve blood flow and reduce strain on the heart.
Hear when a new Pulmonary Embolism Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.